Literature DB >> 374652

Inhibition of alternative complement pathway opsonization by group A streptococcal M protein.

P K Peterson, D Schmeling, P P Cleary, B J Wilkinson, Y Kim, P G Quie.   

Abstract

Group A streptococcal M protein is known to be antiphagocytic; however, the exact basis for this property has not been established. In this study the hypothesis was tested that cell wall--associated M protein inhibits phagocytosis by interfering with bacterial opsonization. Two strains of group A Streptococcus pyogenes, CS44 (M+) and CS64 (an M- variant of CS44), were radiolabeled, and after incubation in serum these organisms were exposed to human polymorphonuclear leukocytes. Phagocytosis was quantitated by measurement of leukocyte-associated radioactivity. The contributions of complement and of immunoglobulin to streptococcal opsonization were evaluated by use of serum from a variety of sources. The results revealed that the M- strain was efficiently opsonized via the alternative complement pathway in a relative absence of immunoglobulins. In contrast, the M+ strain was poorly opsonized by all sera tested. These findings suggest that streptococcal M protein in some way prevents bacterial opsonization via the alternative complement pathway and that this property of M protein may partly explain its antiphagocytic characteristic.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 374652     DOI: 10.1093/infdis/139.5.575

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes.

Authors:  B A Fernie-King; D J Seilly; C Willers; R Würzner; A Davies; P J Lachmann
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

2.  National Department of Defense surveillance data for antibiotic resistance and emm gene types of clinical group A streptococcal isolates from eight basic training military sites.

Authors:  Christopher P Barrozo; Kevin L Russell; Tyler C Smith; Anthony W Hawksworth; Margaret A K Ryan; Gregory C Gray
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

3.  M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H.

Authors:  T K Blackmore; V A Fischetti; T A Sadlon; H M Ward; D L Gordon
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

Review 4.  Common themes in microbial pathogenicity.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Rev       Date:  1989-06

Review 5.  Streptococcal M protein: molecular design and biological behavior.

Authors:  V A Fischetti
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

6.  Chemiluminescent response of polymorphonuclear leukocytes to Streptococcus pneumoniae and Haemophilus influenzae in suspension and adhered to glass.

Authors:  K Hayashi; D A Lee; P G Quie
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

7.  Unimpaired function of human phagocytes in the presence of phagocytosis-resistant group A streptococci.

Authors:  B N Manjula; M L Schmidt; V A Fischetti
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci.

Authors:  E Whitnack; E H Beachey
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

9.  Production of bacteriocin-like inhibitors by group A streptococci of nephritogenic M types.

Authors:  J R Tagg
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

10.  Expression of the Arp protein, a member of the M protein family, is not sufficient to inhibit phagocytosis of Streptococcus pyogenes.

Authors:  L K Husmann; J R Scott; G Lindahl; L Stenberg
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.